Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C.

Camille Nigri Cursino Priscilla Garcia de Oliveira Monteiro Gabriel da Silva Duarte Tassita Bezz Quintanilha Vieira Verônica de Carvalho Crisante Fabíola Giordani Ana Lucia Rampazzo Xavier Renan Moritz Varnier Rodrigues de Almeida Sabrina Calil-Elias

Published in: Pharmacoepidemiology and drug safety (2019)

Direct-acting antiviral has been shown to be safe and effective. Therefore, use of ribavirin is questionable due to associated adverse reactions and similar efficacy to other treatments.

Keyphrases

adverse drug
electronic health record
emergency department
drug induced